1217 related articles for article (PubMed ID: 27662091)
21. Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein.
Lei Y; Zhang X; Su J; Jeong M; Gundry MC; Huang YH; Zhou Y; Li W; Goodell MA
Nat Commun; 2017 Jul; 8():16026. PubMed ID: 28695892
[TBL] [Abstract][Full Text] [Related]
22. Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity.
Siddique AN; Nunna S; Rajavelu A; Zhang Y; Jurkowska RZ; Reinhardt R; Rots MG; Ragozin S; Jurkowski TP; Jeltsch A
J Mol Biol; 2013 Feb; 425(3):479-91. PubMed ID: 23220192
[TBL] [Abstract][Full Text] [Related]
23. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
Nguyen TV; Lister R
Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
[TBL] [Abstract][Full Text] [Related]
24. Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter.
Yossifoff M; Kisliouk T; Meiri N
Eur J Neurosci; 2008 Dec; 28(11):2267-77. PubMed ID: 19046370
[TBL] [Abstract][Full Text] [Related]
25. Targeted DNA methylation in human cells using engineered dCas9-methyltransferases.
Xiong T; Meister GE; Workman RE; Kato NC; Spellberg MJ; Turker F; Timp W; Ostermeier M; Novina CD
Sci Rep; 2017 Jul; 7(1):6732. PubMed ID: 28751638
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
[TBL] [Abstract][Full Text] [Related]
27. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins.
Maeder ML; Angstman JF; Richardson ME; Linder SJ; Cascio VM; Tsai SQ; Ho QH; Sander JD; Reyon D; Bernstein BE; Costello JF; Wilkinson MF; Joung JK
Nat Biotechnol; 2013 Dec; 31(12):1137-42. PubMed ID: 24108092
[TBL] [Abstract][Full Text] [Related]
28. Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions.
Morita S; Noguchi H; Horii T; Nakabayashi K; Kimura M; Okamura K; Sakai A; Nakashima H; Hata K; Nakashima K; Hatada I
Nat Biotechnol; 2016 Oct; 34(10):1060-1065. PubMed ID: 27571369
[TBL] [Abstract][Full Text] [Related]
29. Artificial escape from XCI by DNA methylation editing of the CDKL5 gene.
Halmai JANM; Deng P; Gonzalez CE; Coggins NB; Cameron D; Carter JL; Buchanan FKB; Waldo JJ; Lock SR; Anderson JD; O'Geen H; Segal DJ; Nolta J; Fink KD
Nucleic Acids Res; 2020 Mar; 48(5):2372-2387. PubMed ID: 31925439
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic modifications affect Dnmt3L expression.
Aapola U; Mäenpää K; Kaipia A; Peterson P
Biochem J; 2004 Jun; 380(Pt 3):705-13. PubMed ID: 15015937
[TBL] [Abstract][Full Text] [Related]
31. Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria.
Xiong T; Rohm D; Workman RE; Roundtree L; Novina CD; Timp W; Ostermeier M
PLoS One; 2018; 13(12):e0209408. PubMed ID: 30562388
[TBL] [Abstract][Full Text] [Related]
32. Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress.
Xin YJ; Yuan B; Yu B; Wang YQ; Wu JJ; Zhou WH; Qiu Z
Sci Rep; 2015 Jan; 5():7645. PubMed ID: 25561289
[TBL] [Abstract][Full Text] [Related]
33. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
34. Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.
Sapozhnikov DM; Szyf M
Nat Protoc; 2022 Dec; 17(12):2840-2881. PubMed ID: 36207463
[TBL] [Abstract][Full Text] [Related]
35. Targeted DNA demethylation of the
Gallego-Bartolomé J; Gardiner J; Liu W; Papikian A; Ghoshal B; Kuo HY; Zhao JM; Segal DJ; Jacobsen SE
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2125-E2134. PubMed ID: 29444862
[TBL] [Abstract][Full Text] [Related]
36. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
37. Regulation of CpG methylation by Dnmt and Tet in pluripotent stem cells.
Horii T; Hatada I
J Reprod Dev; 2016 Aug; 62(4):331-5. PubMed ID: 27151232
[TBL] [Abstract][Full Text] [Related]
38. Regulation of gene expression by altered promoter methylation using a CRISPR/Cas9-mediated epigenetic editing system.
Kang JG; Park JS; Ko JH; Kim YS
Sci Rep; 2019 Aug; 9(1):11960. PubMed ID: 31427598
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Gene Expression Patterns of Epigenetic Enzymes
Vágó J; Kiss K; Karanyicz E; Takács R; Matta C; Ducza L; Rauch TA; Zákány R
Cells; 2021 Oct; 10(10):. PubMed ID: 34685658
[TBL] [Abstract][Full Text] [Related]
40. dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression.
O'Geen H; Ren C; Nicolet CM; Perez AA; Halmai J; Le VM; Mackay JP; Farnham PJ; Segal DJ
Nucleic Acids Res; 2017 Sep; 45(17):9901-9916. PubMed ID: 28973434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
